Table 3.
HR | Std. err | p-value | 95% CI | |
---|---|---|---|---|
Short term all-cause mortality (a) | ||||
Age, (1 year increase) | 1.053 | 0.017 | < 0.001 | 1.026–1.091 |
Female Gender | 1.191 | 0.370 | 0.58 | 0.642–2.192 |
Hypertension | 0.663 | 0.199 | 0.171 | 0.368–1.195 |
Smoking | 0.540 | 0.179 | 0.063 | 0.282–1.033 |
Group | ||||
No T2DM–no aHGL | Ref. cat | |||
Only aHGL | 4.221 | 1.748 | 0.001 | 1.867–9.499 |
Only T2DM | – | – | – | – |
aHGL + T2DM | 3.548 | 1.520 | 0.003 | 1.532–8.215 |
Killip class > 1 | 2.711 | 0.904 | 0.003 | 1.410–5.210 |
MINOCA/MIOCA | 0.437 | 0.358 | 0.304 | 0.046–2.614 |
Troponin I Peak IQR | ||||
I | Ref cat | |||
II | 0.367 | 0.262 | 0.160 | 0.090–1.486 |
III | 1.544 | 0.770 | 0.384 | 0.581–4.105 |
IV | 3.120 | 1.440 | 0.014 | 1.262–7.712 |
Long term all-cause mortality (b) | ||||
Age (years) | 1.093 | 0.009 | < 0.001 | 1.076–1.110 |
Female Gender | 0.891 | 0.133 | 0.441 | 0.665–1.194 |
Hypertension | 1.600 | 0.315 | 0.017 | 1.088–2.354 |
Smoking habit | 1.150 | 0.179 | 0.119 | 0.944–1.654 |
Group | ||||
No T2DM–no aHGL | Ref. Cat | |||
Only aHGL | 1.708 | 0.294 | 0.002 | 1.219–2.394 |
Only T2DM | 1.698 | 0.454 | 0.047 | 1.006–2.866 |
aHGL + T2DM | 1.870 | 0.310 | < 0.001 | 1.351–2.588 |
Discharge LVEF | 0.967 | 0.006 | < 0.001 | 0.955–0.979 |
NSTEMI/STEMI | 1.116 | 0.152 | 0.419 | 0.855–1.224 |
Left main | 0.919 | 0.134 | 0.564 | 0.691–1.224 |
MINOCA/MIOCA | 1.377 | 0.330 | 0.182 | 0.862–2.201 |
no-aHGL admission normal glucose level, aHGL admission high glucose level, T2DM type 2 diabetes mellitus, LVEF left ventricular ejection fraction, NSTEMI Non-ST-segment elevation myocardial infarction, STEMI ST-segment elevation myocardial infarction